{"name":"Chiesi SAS","slug":"chiesi-sas","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Life-Cycle Pharma Tacrolimus","genericName":"Life-Cycle Pharma Tacrolimus","slug":"life-cycle-pharma-tacrolimus","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Life-Cycle Pharma Tacrolimus","genericName":"Life-Cycle Pharma Tacrolimus","slug":"life-cycle-pharma-tacrolimus","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipAJBVV95cUxQbjUySllaWVNQbnh5d2IzQXExaS1fVlRiVFhRWUdDdEFHbVRyVnctdVZKRFA3QmVHZEgzYnI4YnphWFZaQWlUekV4QjJGSTRTQk9rQm54VG1hQXhYcjl5a0dvOXp3TC1LY2ppU1pTWGhwVWhoZ3JiZDBKUE9QUHFDc3owbDlYWmV6WWcza3Z0SFRrQjdnbHdIZXVrRXpMWkprd1NJT09oNF82ZU0tMHJMX3A2bE51WXIzNFlnNXV4R2xrbFdNSldwX3VyUzlrd01tV2NLeHNHYngtaU5kOHRtNDBkUjV3aENUOHNKYlU3Y08yMkhPUm1NcXE1R0NsZWtUMGdXV1RFd0xZbGhvRnNIbUlxc1l1aXRUVk5WTWhPMVBxUjlC?oc=5","date":"2025-02-07","type":"pipeline","source":"PR Newswire","summary":"Effervescent Tablet Market to Grow by USD 4.80 Billion (2024-2028), Boosted by Aging Population Adoption & AI's Impact on Market Trends - Technavio - PR Newswire","headline":"Effervescent Tablet Market to Grow by USD 4.80 Billion (2024-2028), Boosted by Aging Population Adoption & AI's Impact o","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5UbTN4ZHhZVW9QNkVDcWNqYkZoN0VVcGRzRUFfbjUtd1FSY3dKZXBWQjVHM0JkRl9YbEdnQXh2em1fUnBnMnFPWV9hV3hnOTBNYzc4Vm5zaFZmaW9WRC1iQ3hoS3ZXcmI4d096VFRB?oc=5","date":"2023-08-03","type":"regulatory","source":"Straits Research","summary":"Effervescent Tablet Market Size, Top Share, Demand, Forecast to 2033 - Straits Research","headline":"Effervescent Tablet Market Size, Top Share, Demand, Forecast to 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE5KOWlPS3RxcVpDZC1hNm1vaFJXVUhJUURjRzdzQjJPZkZGNWxWYk15Q1UwNTVUdk5JbUJ0aVRINDlkTXctdDI1eVZ5THpRMGk1amZHSjgzU1JjYUtVc2xfc1BQYklhQnJPVGxwdw?oc=5","date":"2023-02-13","type":"trial","source":"SAS: Data and AI Solutions","summary":"Advanced analytics in the cloud helps international biopharmaceutical group enhance operations and efficiency - SAS: Data and AI Solutions","headline":"Advanced analytics in the cloud helps international biopharmaceutical group enhance operations and efficiency - SAS: Dat","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}